JAK2

There are 172 papers on JAK2 in aging research: 5 trials and 41 observational studies in people, 69 in animals, 17 in cells, 29 reviews. The newest story, Nov 11, 2026: “Cell-to-cell signals help build artery plaque caps in mice”.

Gene

172 papers study it38 findings

HGNCNCBI GeneTaxon

13 new papers in 30 daysSee all 172 papers on JAK2

At a glance

A human study using solid tumor next-generation sequencing associates JAK2 with clonal myeloid processes and myeloid neoplasms.

38 findings in 24 papers from 2016 to 2026, 4 of them since May 2026

The findings reach people, from one lab or study. 14 independent labs in 5 countries; 148 trials, 11 with no results posted.

“JAK2 mutations were highly associated with both prevalent and incident VTE risk, with an OR of 6.58 (95% CI, 2.65-16.29; P = 4.7 × 10-5)”
JAK2-mutant clonal hematopoiesis is associated with venous thromboembolismBlood2024doi:10.1182/blood.2024024187

None of its findings points the other way.

Cells, mice and humans: a single group. Worms or flies: nothing yet.
  • 14 independent labs in 5 countries
  • 148 trials, 11 with no results posted
  • Funders: National Institutes of Health and others
  • 3 of 33 findings with company ties
  • 99 of 148 trials sponsored by developers of drugs aimed at it
  • Human trial5
  • Humans41
  • Animals69
  • Cells17
  • In silico8

Interventions

1

Caloric restriction + exercise

upin humans1

1 study
  1. Caloric restriction + exercise increases JAK2 in humans.

    “Compared with PRE, after CD, phospho-Tyr1141OBR, phospho-Tyr985OBR, JAK2, and phospho-Tyr1007/1008JAK2 protein expression were increased in all muscles”

    Human trialskeletal muscle3 daysmalesn = 15

    Severe energy deficit upregulates leptin receptors, leptin signaling, and PTP1B in human skeletal muscle

    Journal of applied physiology (Bethesda, Md. : 1985)

More on Caloric restriction + exercise

Effects

24

Cardiac microvascular disease

upin mice1

1 study
  1. JAK2 induces cardiac microvascular disease in mice under cardiometabolic stress.

    “Mice with JAK2V617F-mutant blood cells developed a distinct cardiovascular phenotype characterized by microvascular disease, increased left ventricular mass, and relatively preserved left ventricular ejection fraction.”

    Animalsunder cardiometabolic stress

    Antibody reduced small-vessel heart damage in mice

    Arteriosclerosis, thrombosis, and vascular biology

More on Cardiac microvascular disease

Nurr1 transcriptional activity

upin human cells1

1 study
  1. JAK2 increases Nurr1 transcriptional activity in SK-N-BE(2)C neuroblastoma cells.

    “overexpression of JAK2 modestly enhanced Nurr1 transcriptional activity, while the constitutively active mutant JAK2 V617F markedly increased it”

    Cellsin SK-N-BE(2)C neuroblastoma cells

    Janus kinase 2 regulates Nurr1 protein stability in dopaminergic neurons of the aging midbrain

    bioRxiv : the preprint server for biologyPreprint

More on Nurr1 transcriptional activity

Nurr1 protein stability

upin human cells1

1 study
  1. JAK2 increases Nurr1 protein stability in SK-N-BE(2)C neuroblastoma cells.

    “expression of JAK2 V617F increased Nurr1 protein levels without altering its mRNA expression”

    Cellsin SK-N-BE(2)C neuroblastoma cells

    Janus kinase 2 regulates Nurr1 protein stability in dopaminergic neurons of the aging midbrain

    bioRxiv : the preprint server for biologyPreprint

More on Nurr1 protein stability

Functional outcome

downin humans1OR 2.74

1 study
  1. JAK2 is linked with worse functional outcome in humans following stroke (adjusted OR 2.74 [1.07, 6.49]).

    “Mutation carriers manifested significantly inferior functional outcomes following stroke relative to non-carriers (adjusted OR 2.74[1.07, 6.49]).”

    Humansfollowing stroke

    JAK2 pathogenic variants in ischemic stroke: low prevalence and pre-screening model

    Journal of neurology

Transposable element activity

upin mice1

1 study
  1. JAK2 activates transposable element activity in mice (JAK2V617F mutation with aging).

    “aged mutant MK showed marked upregulation of long-interspersed element-1 (LINE-1) retrotransposon transcripts alongside elevated innate immune sensors cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING)”

    AnimalsJAK2V617F mutation with agingbone marrow

    Immunomodulatory role of megakaryocytes in the hematopoietic niche of myeloproliferative neoplasms

    Haematologica

More on Transposable element activity

Inflammation

upin mice1

1 study
  1. JAK2 increases inflammation in mice (MK-restricted JAK2V617F expression in aged mice).

    “aged mutant MK exhibit enhanced antigen uptake and MHC I presentation, secretion of pro-inflammatory cytokines (PF4, TGFβ, IL-1β), and induction of T-cell dysregulation”

    AnimalsMK-restricted JAK2V617F expression in aged micebone marrow

    Immunomodulatory role of megakaryocytes in the hematopoietic niche of myeloproliferative neoplasms

    Haematologica

More on Inflammation

Thrombosis

downin humans1OR 0.998

1 study
  1. JAK2 is linked with less thrombosis in humans (OR = 0.998, p = 0.028).

    “MR suggested that higher JAK2 expression was protective against thrombosis (OR = 0.998, p = 0.028)”

    Humans

    Differential risk of adverse drug reactions with baricitinib across age groups: integrating real-world pharmacovigilance and genetic causal inference

    Therapeutic advances in drug safety

More on Thrombosis

Glycogen breakdown

downin mouse cells1

1 study
  1. JAK2 decreases glycogen breakdown in mouse cells (isolated aged neutrophils).

    “decreases glycogen breakdown in aged cells”

    Cellsisolated aged neutrophils

    Aging changes the mechanism that underlies JAK2 modulation of neutrophil function

    Journal of immunology (Baltimore, Md. : 1950)

Neutrophil extracellular trap production

upin mouse cells1

1 study
  1. JAK2 increases neutrophil extracellular trap production in mouse cells (isolated neutrophils).

    “JAK2 primes ROS production by altering NADPH oxidase components, which contributes to NET production.”

    Cellsisolated neutrophils

    Aging changes the mechanism that underlies JAK2 modulation of neutrophil function

    Journal of immunology (Baltimore, Md. : 1950)

More on Neutrophil extracellular trap production

Oxidative stress and ROS signaling

upin mouse cells1

1 study
  1. JAK2 increases oxidative stress and ROS signaling in mouse cells (isolated neutrophils).

    “JAK2 primes ROS production by altering NADPH oxidase components, which contributes to NET production.”

    Cellsisolated neutrophils

    Aging changes the mechanism that underlies JAK2 modulation of neutrophil function

    Journal of immunology (Baltimore, Md. : 1950)

More on Oxidative stress and ROS signaling

All 24

Associations

12

Clonal hematopoiesis of indeterminate potential

upin humans1upin reviews1

2 studies
  1. JAK2 is associated with clonal hematopoiesis of indeterminate potential in humans (somatic mutation).

    “CHIP is driven by somatic mutations in leukaemia driver genes, such as Janus Kinase 2 (JAK2)”

    Reviewsomatic mutation

    Clonality in haematopoietic stem cell ageing

    Mechanisms of ageing and development

  2. JAK2 is associated with clonal hematopoiesis of indeterminate potential during aging.

    “JAK2 mutations are among the most frequently mutated genes in blood cells during aging.”

    Reviewduring aging

    Roles of JAK2 in Aging, Inflammation, Hematopoiesis and Malignant Transformation

    Cells

More on Clonal hematopoiesis of indeterminate potential

Myeloid neoplasm

upin humans1

1 study
  1. JAK2 is associated with myeloid neoplasm in humans (solid tumour NGS) (6/12 patients).

    “6/12 patients had evidence of a JAK2 V617F positive myeloid neoplasm”

    Humanssolid tumour NGSn = 12

    Incidental detection of JAK2 V617F mutations in next-generation sequencing analysis of solid tumours: a guide to further workup

    Journal of clinical pathology

More on Myeloid neoplasm

Clonal myeloid process

upin humans1

1 study
  1. JAK2 is associated with clonal myeloid process in humans (solid tumour NGS) (8/12 patients).

    “8/12 patients had clinical history or laboratory evidence of an underlying clonal myeloid process”

    Humanssolid tumour NGSn = 12

    Incidental detection of JAK2 V617F mutations in next-generation sequencing analysis of solid tumours: a guide to further workup

    Journal of clinical pathology

More on Clonal myeloid process

Acute coronary syndrome

upin humans1

1 study
  1. JAK2 is associated with acute coronary syndrome in ACS patients (6.1% vs 3.1%).

    “The JAK2V617F mutation was detected in 6.1% (32/526) of ACS patients, significantly higher than the general population prevalence (3.1%).”

    Humansin ACS patientsn = 526

    High Prevalence of the JAK2V617F Mutation in Patients With Acute Coronary Syndrome

    European journal of haematology

More on Acute coronary syndrome

Therapy-related myeloid neoplasms

upin humans1RR 9.42

1 study
  1. JAK2 is linked with a higher risk of therapy-related myeloid neoplasms in humans (progression from therapy-related clonal hematopoiesis) (RR 9.42).

    “Genes that imparted significantly increased risk for progression from t-CH to overt therapy-related myeloid neoplasm (t-MN) included JAK2 (relative risk (RR) 9.42, p = 0.0001)”

    Humansprogression from therapy-related clonal hematopoiesis

    Ontogeny and Natural History of Therapy-Related Clonal Hematopoiesis From a Multidisciplinary CHIP Clinic

    American journal of hematology

More on Therapy-related myeloid neoplasms

Pulmonary embolism

upin humans1

1 study
  1. JAK2 raises the risk of pulmonary embolism in humans (human studies).

    “JAK2-CHIP and TET2-CHIP show the most consistent associations with VTE/PE”

    Reviewhuman studies

    Clonal Hematopoiesis (CHIP) in Pulmonary Embolism and CTEPH: Evidence, Mechanisms, and Risk Stratification

    International journal of molecular sciences

More on Pulmonary embolism

JAK2 V617F screening score

upin humans1

1 study
  1. JAK2 V617F screening score predicts JAK2 in humans (cut-off score of 3 points) (AUC 0.98, sensitivity 85%, specificity 94%, accuracy 94%).

    “We constructed the JAK2 V617F screening score, which efficiently discriminated between carriers and non-carriers (area under the ROC curve, AUC 0.98)”

    Humanscut-off score of 3 points

    JAK2 pathogenic variants in ischemic stroke: low prevalence and pre-screening model

    Journal of neurology

More on JAK2 V617F screening score

Myeloproliferative neoplasm

upin mice1

1 study
  1. JAK2 is associated with myeloproliferative neoplasm in mice (chimeric mice with co-existing wild-type and JAK2V617F mutant hematopoietic cells).

    “enhanced MK immune activity correlates with mutant cell expansion and MPN development”

    Animalschimeric mice with co-existing wild-type and JAK2V617F mutant hematopoietic cellsbone marrow

    Immunomodulatory role of megakaryocytes in the hematopoietic niche of myeloproliferative neoplasms

    Haematologica

More on Myeloproliferative neoplasm

Cardiovascular death

upin humans1

1 study
  1. JAK2 is linked with a higher risk of cardiovascular death in humans (aHR 2.62 (95% CI: 1.68-4.11)).

    “JAK2 CHIP with ischemic stroke (aHR: 2.49 [95% CI: 1.17-5.30]; P = 0.02), venous thromboembolism (aHR: 2.71 [95% CI: 1.11-6.65]; P = 0.03), and cardiovascular death (aHR: 2.62 [95% CI: 1.68-4.11]; P < 0.001)”

    Humansmedian follow-up 10.1 yearsfemalesn = 6,677

    Clonal Hematopoiesis and Cardiovascular Outcomes in Older Women

    Journal of the American College of Cardiology

Venous thromboembolism

upin humans1OR 6.58

1 study
  1. JAK2 is associated with venous thromboembolism in humans (prevalent VTE) (OR 6.58 (95% CI, 2.65-16.29)).

    “JAK2 mutations were highly associated with both prevalent and incident VTE risk, with an OR of 6.58 (95% CI, 2.65-16.29; P = 4.7 × 10-5)”

    Humansprevalent VTEn = 400,000

    JAK2-mutant clonal hematopoiesis is associated with venous thromboembolism

    Blood

More on Venous thromboembolism

All 12

Funding

1 grant since 2018

São Paulo Research Foundation

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 5Jan 2026: 8Feb 2026: 9Mar 2026: 8Apr 2026: 4May 2026: 6Jun 2026: 4Jul 2026: 2Aug 2026: 5Sep 2026: 7Oct 2026: 13Nov 2026: 273 papers in 12 months
bioRxiv

Cell-to-cell signals help build artery plaque caps in mice

In mice carrying a blood-cell mutation, activating an immune-cell protein promoted plaque cap formation through signals between immune cells and connective-tissue cells.In mice carrying a blood-cell mutation, activating an immune-cell protein promoted plaque cap formation through signals between immune cells and connective-tissue cells.

Preprint: mouse studyMechanisms
Blood Advances

Monitoring detected blood cancers with less marrow scarring

The median share of JAK2 gene copies carrying a mutation was 13.0% at diagnosis in monitored cases versus 41.3% in referral-diagnosed cases.The median share of JAK2 gene copies carrying a mutation was 13.0% at diagnosis in monitored cases versus 41.3% in referral-diagnosed cases.

Cohort · 61 peopleInterventions
Research Square

Deleting an immune-related gene eased bone loss in female mice

An experiment compared female mice with and without an immune-regulating gene after ovary removal, finding higher bone density in mice without it.An experiment compared female mice with and without an immune-regulating gene after ovary removal, finding higher bone density in mice without it.

Preprint: mouse studyBones and joints
ESC Congress 2026 Abstract

Blood mutations linked to heart, kidney, and metabolic disease

Participants with age-related expansion of mutated blood cells had an adjusted hazard ratio of 1.11 for progression to syndrome stage 4 compared with participants without…Participants with age-related expansion of mutated blood cells had an adjusted hazard ratio of 1.11 for progression to syndrome stage 4 compared with participants without the condition.

See all 172 papers on JAK2